Skip to Content
Find More Like This
Return to Search

EGVII Endoglucanase and Nucleic Acids Encoding the Same

United States Patent Application

20150299683
A1
View the Complete Application at the US Patent & Trademark Office
National Renewable Energy Laboratory - Visit the NREL Technology Transfer Website
The present invention provides a novel endoglucanase nucleic acid sequence, designated egl7, and the corresponding EGVII amino acid sequence. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding EGVII, recombinant EGVII proteins and methods for producing the same.
DUNN-COLEMAN, Nigel (El Sauzal, ES), GOEDEGEBUUR, Frits (Vlaardingen, NL), WARD, Michael (San Francisco, CA), YAO, Jian (Sunnyvale, CA)
DANISCO US INC. (Palo Alto CA)
14/ 671,603
March 27, 2015
GOVERNMENT SUPPORT [0001] Portions of this work were funded by Subcontract No. ZCO-30017-01 with the National Renewable Energy Laboratory under Prime Contract No. DE-AC36-99GO10337 with the U.S. Department of Energy. Accordingly, the United States Government may have certain rights in this invention. CROSS REFERENCE TO RELATED APPLICATIONS [0002] This application is a continuation of U.S. application Ser. No. 14/159,044, now U.S. Pat. No. 9,005,948, which is a continuation of U.S. application Ser. No. 13/920,043, now U.S. Pat. No. 8,658,406, which is a divisional of U.S. application Ser. No. 13/286,955, filed on Nov. 1, 2011, now U.S. Pat. No. 8,486,667, which is a continuation of U.S. application Ser. No. 12/250,316, filed on Oct. 13, 2008, now U.S. Pat. No. 8,114,655, which is a continuation of U.S. application Ser. No. 11/329,498, filed Jan. 10, 2006, now U.S. Pat. No. 7,449,319, which is a divisional of U.S. application Ser. No. 10/028,244, filed on Dec. 18, 2001, now U.S. Pat. No. 7,045,331.